CM
LLY icon

Crestline Management’s Eli Lilly LLY Stock Holding History

Crestline Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,241
Closed -$12.5M – 364
2024
Q4 		$12.5M Buy
16,241
+14,041
+638% +$11.6M 0.42% 34
2024
Q3 		$1.95M Buy
+2,200
New +$1.98M 0.1% 192
2018
Q3 		– Sell
-11,786
Closed -$1.01M – 197
2018
Q2 		$1.01M Buy
+11,786
New +$968K 0.11% 195
2017
Q1 		– Sell
-3,889
Closed -$286K – 128
2016
Q4 		$286K Sell
3,889
-6,825
-64% -$508K 0.07% 72
2016
Q3 		$860K Buy
+10,714
New +$858K 0.11% 98

Other funds holding LLY

PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Crestline Management's LLY Position: Q1 2025 in Review

Crestline Management sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 16,241 shares — an estimated $12.5M sold.

Crestline Management first reported a position in LLY in Q3 2016 and held it in 5 quarters. The position peaked at $12.5M in Q4 2024. 3,919 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • Crestline Management reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
  • Crestline Management sold 16,241 Eli Lilly shares in Q1 2025, an estimated $12.5M.
  • Crestline Management first reported a position in Eli Lilly in Q3 2016 and held it in 5 quarters.
  • Crestline Management's Eli Lilly position peaked at $12.5M in Q4 2024.
  • 3,919 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.